NCT06222398

Brief Summary

The purpose of this study is to observe current exoskeleton users in their home environment to determine the activities of daily living (ADLs) they are able to complete, and to identify the minor adaptations to the home environment that will improve the exoskeleton user's potential for increased independence. This is a pilot study to fine-tune the methods and to determine the feasibility of doing this study on a larger scale.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 18, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 24, 2024

Completed
17 days until next milestone

Study Start

First participant enrolled

February 10, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 28, 2025

Completed
Last Updated

January 22, 2026

Status Verified

October 1, 2025

Enrollment Period

1.9 years

First QC Date

December 18, 2023

Last Update Submit

January 20, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Reintegration to Normal Living Index - Modified for Exoskeleton

    Assesses quantitatively the degree to which individuals who have experienced traumatic or incapacitating illness achieve reintegration into normal social activities. This assessment has been modified from wheelchair level to exoskeleton level. The Reintegration to Normal Living Index has 9 Likert-style items. Each item is accompanied by verbal label choices with phrases reflecting how important the situation described is to the patient as it relates to using the exoskeleton. It allows the patients to determine the extent to which the statement in question applies to their specific situation.

    baseline results will be collected same day as the home visit, same assessment will be repeated virtually at 1, 3, 6, 9, and 12 months

  • Brief Pain Inventory (BPI)

    The BPI allows patients to rate the severity of their pain and the degree to which their pain interferes with common dimensions of feeling and function. A higher score on the BPI indicates more severe pain. Scores can range from 0-10. The BPI scale defines pain as follows: Worst Pain Score: 1 - 4 = Mild Pain. Worst Pain Score: 5 - 6 = Moderate Pain. Worst Pain Score: 7 - 10 = Severe Pain.

    baseline results will be collected same day as the home visit, same assessment will be repeated virtually at 1, 3, 6, 9, and 12 months

  • Canadian Occupational Performance Measure (COPM)

    The COPM assesses an individual's perceived occupational performance in the areas of self-care, productivity, and leisure. The COPM identifies 5 functional tasks the patient wants to improve, and rates their performance and satisfaction in their performance. Tasks are scored on a 1-10 scale (1-low; 10-high) for each item, then averaged over the 5 areas for an overall score. A higher score indicates better performance.

    baseline results will be collected same day as the home visit, same assessment will be repeated virtually at 1, 3, 6, 9, and 12 months

Secondary Outcomes (1)

  • Journal Entries

    check journal monthly up to 12 months

Study Arms (1)

Exoskeleton Users

This study includes patients who are current exoskeleton users. Exoskeleton users will engage in normal activities of daily living (ADLs) that they currently perform at wheelchair level while using the exoskeleton. Researchers will observe the ADLs the exoskeleton users are and are not able to complete while using their exoskeleton.

Device: Exoskeleton

Interventions

The study will include one group of patients who are current exoskeleton users.

Exoskeleton Users

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The population for this study is current exoskeleton users.

You may qualify if:

  • At least 18 years old
  • English speaking
  • Trained and approved/credentialed by exoskeleton manufacturer to use the device independently according to FDA approved activities

You may not qualify if:

  • Does not speak English
  • \<18 years of age
  • Has not been cleared by manufacturer for independent exoskeleton use

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

A. T. Still University

Mesa, Arizona, 85206, United States

Location

MeSH Terms

Conditions

Paraplegia

Interventions

Exoskeleton Device

Condition Hierarchy (Ancestors)

ParalysisNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Equipment and Supplies

Study Officials

  • Sue Dahl-Popolizio, DBH

    A. T. Still University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 18, 2023

First Posted

January 24, 2024

Study Start

February 10, 2024

Primary Completion

December 28, 2025

Study Completion

December 28, 2025

Last Updated

January 22, 2026

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations